International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Zhvillimi i Biznesit
Media
Na takoni
Karriera
Na kontaktoni
Partnerët dhe Brendet
Referencat
Rreth Ewopharma
Vizioni/Misioni
Vlerat Tona
Strategjia Jonë
Lidershipi
Përgjegjësia e Korporatës
TerritorI
Zhvillimi i Biznesit
Media
Na takoni
Karriera
Na kontaktoni
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Media
Lajme
1
2
3
Tjetra
15.04.2026
Sugemalimab Receives I, A Recommendation in ESMO Guideline for Consolidation Therapy in Patients with Stage Ⅲ NSCLC
Lexo më shumë
26.02.2026
BioGaia AB extends long-standing distribution partnership with Ewopharma
Lexo më shumë
16.12.2025
Sugemalimab Achieves New Regulatory Milestone: European Commission Approves Stage Ⅲ NSCLC Indication
Lexo më shumë
26.07.2024
European Commission Approves Sugemalimab
Lexo më shumë
03.06.2024
Allergycare AG becomes part of Ewopharma Group
Lexo më shumë
1
2
3
Tjetra
![[Translate to Kosovo - Albanian:]](/fileadmin/user_upload/Ewopharma_CStone_Sugemalimab_01.png "[Translate to Kosovo - Albanian:]")
